http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-116989-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a693232b92910547c898db10feb83fef |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate | 2019-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-116989-A1 |
| titleOfInvention | 5,8-DIMETHYL-2- [2- (1-METHYL-4-PHENYL-1H-IMIDAZOL-2-IL) ETHYL] [1,2,4] TRIAZOLO [1,5-A] PYRAZINE HEMIADIPATE |
| abstract | This refers to 5,8-dimethyl-2- [2- (1-methyl-4-phenyl-1H-imidazol-2-yl) ethyl] [1,2,4] triazolo [1,5- a] pyrazine, which is non-hygroscopic. The present also relates to pharmaceutical compositions comprising 5,8-dimethyl-2- [2- (1-methyl-4-phenyl-1H-imidazol-2-yl) ethyl] [1,2,4] triazolo hemiadipate [1,5-a] pyrazine, as well as the use of 5,8-dimethyl-2- [2- (1-methyl-4-phenyl-1H-imidazol-2-yl) ethyl] [1,2 , 4] triazolo [1,5-a] pyrazine in therapy. The 5,8-dimethyl-2- [2- (1-methyl-4-phenyl-1H-imidazol-2-yl) ethyl] [1,2,4] triazolo [1,5-a] pyrazine hemiadipate which shown in formula (1). Claim 1: A hemiadipate of the compound of formula (1) with the chemical name: 5,8-dimethyl-2- [2- (1-methyl-4-phenyl-1H-imidazol-2-yl) ethyl] [1, 2,4] triazolo [1,5-a] pyrazine. |
| priorityDate | 2018-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 20.